| Style | Citing Format | 
|---|---|
| MLA | Mohseni S, et al.. "The Effectiveness of Negative Pressure Wound Therapy As a Novel Management of Diabetic Foot Ulcers: An Overview of Systematic Reviews." Journal of Diabetes and Metabolic Disorders, vol. 18, no. 2, 2019, pp. 625-641. | 
| APA | Mohseni S, Aalaa M, Atlasi R, Mohajeri Tehrani MR, Sanjari M, Amini MR (2019). The Effectiveness of Negative Pressure Wound Therapy As a Novel Management of Diabetic Foot Ulcers: An Overview of Systematic Reviews. Journal of Diabetes and Metabolic Disorders, 18(2), 625-641. | 
| Chicago | Mohseni S, Aalaa M, Atlasi R, Mohajeri Tehrani MR, Sanjari M, Amini MR. "The Effectiveness of Negative Pressure Wound Therapy As a Novel Management of Diabetic Foot Ulcers: An Overview of Systematic Reviews." Journal of Diabetes and Metabolic Disorders 18, no. 2 (2019): 625-641. | 
| Harvard | Mohseni S et al. (2019) 'The Effectiveness of Negative Pressure Wound Therapy As a Novel Management of Diabetic Foot Ulcers: An Overview of Systematic Reviews', Journal of Diabetes and Metabolic Disorders, 18(2), pp. 625-641. | 
| Vancouver | Mohseni S, Aalaa M, Atlasi R, Mohajeri Tehrani MR, Sanjari M, Amini MR. The Effectiveness of Negative Pressure Wound Therapy As a Novel Management of Diabetic Foot Ulcers: An Overview of Systematic Reviews. Journal of Diabetes and Metabolic Disorders. 2019;18(2):625-641. | 
| BibTex | @article{ author = {Mohseni S and Aalaa M and Atlasi R and Mohajeri Tehrani MR and Sanjari M and Amini MR}, title = {The Effectiveness of Negative Pressure Wound Therapy As a Novel Management of Diabetic Foot Ulcers: An Overview of Systematic Reviews}, journal = {Journal of Diabetes and Metabolic Disorders}, volume = {18}, number = {2}, pages = {625-641}, year = {2019} } | 
| RIS | TY  - JOUR AU - Mohseni S AU - Aalaa M AU - Atlasi R AU - Mohajeri Tehrani MR AU - Sanjari M AU - Amini MR TI - The Effectiveness of Negative Pressure Wound Therapy As a Novel Management of Diabetic Foot Ulcers: An Overview of Systematic Reviews JO - Journal of Diabetes and Metabolic Disorders VL - 18 IS - 2 SP - 625 EP - 641 PY - 2019 ER -  |